8 completed, 3 unknown, 2 terminated, 1 not yet recruiting. 5 Phase 3, 4 Not applicable, 4 Phase 2, 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 5 | Completed 3, Not yet recruiting 1, Unknown 1 |
| Not applicable | 4 | Completed 2, Terminated 1, Unknown 1 |
| Phase 2 | 4 | Completed 2, Terminated 1, Withdrawn 1 |
| Phase 4 | 2 | Completed 1, Unknown 1 |
Follow Fusidic Acid: new trials by email Literature Review of Fusidic Acid trials Research Report on Fusidic Acid
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Antimicrobial Adjuvants to Revert the Imbalance of Skin Microbiota for Improved Outcomes of Complicated Cutaneous Leishmaniasis Treatment in Ethiopia Fusidic Acid, Vehicle cream - Leishmaniasis, Cutaneous | Phase 3 | Not yet recruiting | Institute of Tropical Medicine, Belgium | 180 | 2025-04-01 | 2024-11-19 |
| Study to Determine the Efficacy&Safety of ARV-1801(ACG-701) for the Treatment of Cystic Fibrosis Pulmonary Exacerbations Sodium Fusidate, Placebo - Cystic Fibrosis, Cystic Fibrosis Pulmonary Exacerbation | Phase 2 | Withdrawn | Aceragen | 2023-02-10 | 2023-07-19 | |
| Effectiveness of Sodium Fusidate Ointment Compared to Petrolatum for Wound Healing Following Cauterization Sodium Fusidate 2 % Topical Ointment, Petrolatum ointment - Seborrheic Keratosis, Acrochordon | Not applicable | Completed | Universitas Indonesia | 22 | 2021-01-01 | 2022-05-05 |
| Tedizolid Prolonged Treatment for Prosthetic Joint Infections Tedizolid Phosphate 200 MG [Sivextro] - Prosthetic Joint Infection | Not applicable | Completed | Tourcoing Hospital | 35 | 2018-08-28 | 2021-09-08 |
| S. Aureus Decolonization in HPN Patients. Doxycycline, Trimethoprim, Sulfamethoxazole/trimethoprim - Staphylococcus Aureus, Motility Disorder | Not applicable | Terminated | Radboud University Medical Center | 63 | 2018-02-08 | 2022-05-31 |
| Efficacy of Combining Topical Antibiotic/Steroid/Moisturizer Therapy Compared to Active Comparator in Atopic Dermatitis. Polyethylene glycol hexadecyl ether & Betamethasone valerate cream 0.1%, Fusidic acid, polyethylene glycol hexadecyl ether & Betamethasone valerate cream 0.1% - Severe Atopic Dermatitis | Not applicable | Unknown | Red Cross War Memorial Childrens Hospital | 78 | 2017-11-01 | 2017-09-25 |
| The Efficacy of Permethrin 5%, Fusidic Acid 1% and Synthomycine 5% for Demodex - Blepharitis Permethrin 5%, Synthomycine 5%, Fusidic Acid 1% M/R Eye Drops - Inflammation of the Eyelids | Phase 4 | Unknown | Barzilai Medical Center | 75 | 2017-04-28 | 2018-01-30 |
| Oral Sodium Fusidate (CEM-102) for the Treatment of Staphylococcal Bone or Joint Infections sodium fusidate - Refractory Bone or Joint Infections | Phase 2 / Phase 3 | Completed | Arrevus Inc. | 30 | 2015-12-01 | 2020-01-30 |
| Oral Sodium Fusidate (CEM-102) Versus Oral Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections sodium fusidate, linezolid - Acute Bacterial Skin and Skin Structure Infections | Phase 3 | Completed | Arrevus Inc. | 716 | 2015-11-01 | 2019-04-19 |
| Safety and Efficacy of CEM-102 With Rifampin Compared to Standard Therapy in Patients With Prosthetic Joint Infections or Spacer Infection CEM-102, IV or Oral standard of care antibiotics, Rifampin - Prosthetic Joint Infections of Hip, Prosthetic Joint Infections of Knee | Phase 2 | Terminated | Arrevus Inc. | 14 | 2012-12-01 | 2019-04-19 |
| Scars After Central Venous Catheters Betamethason-17-valerate and fusidic acid, Fusidic Acid - Hypertrophic Scars, Keloids | Phase 3 | Unknown | Mette Møller Handrup | 60 | 2010-03-01 | 2014-02-12 |
| Safety and Efficacy of CEM-102 Compared to Linezolid in Acute Bacterial Skin Infections CEM-102, Linezolid - Skin Diseases, Bacterial | Phase 2 | Completed | Arrevus Inc. | 198 | 2009-08-01 | 2019-04-19 |
| A Study of Verutex (Fusidic Acid), Eritex (Erythromycin) and Fisiogel in the Management of Tarceva-Associated Rash. erlotinib [Tarceva], fusidic acid [Verutex], erythromycin [Eritex] - Non-Small Cell Lung Cancer | Phase 3 | Completed | Hoffmann-La Roche | 201 | 2009-04-01 | 2015-01-15 |
| EU PV for Retapamulin-Prescribing Retapamulin, Co-prescription of retapamulin and topical mupirocin, Co-prescription of retapamulin and topical fusidic acid - Impetigo | Completed | GlaxoSmithKline | 1 | 2008-11-01 | 2013-06-10 | |
| Antibiotic Treatment Duration for Non-Surgically-Treated Diabetic Foot Osteomyelitis duration of the antibiotic therapy - Diabetes Mellitus | Phase 4 | Completed | Tourcoing Hospital | 40 | 2007-06-01 | 2014-04-25 |
Carcinoma, Non-Small-Cell Lung (1) · Cellulitis (1) · Cicatrix, Hypertrophic (1) · Cystic Fibrosis (1) · Dermatitis, Atopic (1) · Diabetes Mellitus (1) · Eczema (1) · Impetigo (1) · Intestinal Failure (1) · Keloid (1) · Keratosis, Seborrheic (1) · Leishmaniasis, Cutaneous (1) · Neoplasms (1) · Osteomyelitis (1) · Skin Diseases, Bacterial (1)
Arrevus Inc. (4) · Tourcoing Hospital (2) · Aceragen (1) · Barzilai Medical Center (1) · GlaxoSmithKline (1) · Hoffmann-La Roche (1) · Institute of Tropical Medicine, Belgium (1) · Mette Møller Handrup (1) · Radboud University Medical Center (1) · Red Cross War Memorial Childrens Hospital (1) · Universitas Indonesia (1)
United States (5) · Denmark (2) · France (2) · Brazil (1) · Ethiopia (1) · Indonesia (1) · Israel (1) · Netherlands (1) · Puerto Rico (1) · South Africa (1)
Alina Tone, MD (1) · Dr Carol Hlela, MBCHB (1) · Eric M Senneville, MD, PhD (1) · Firman Parrol, MD (1) · Henrik Hasle, Professor (1) · Johan Van Griensven, Prof (1) · Joost PH Drenth, MD, PhD (1) · Richard Pushkin, MD (1) · Robert Dobbins, MD, PhD (1)
PMID 14986270, PMID 15329363, PMID 16982292, PMID 18818959, PMID 20176900, PMID 20675299, PMID 21546629, PMID 22157324, PMID 23926058, PMID 23988422, PMID 25135090, PMID 25139552, PMID 25331703, PMID 25414157, PMID 25650692, PMID 26232669, PMID 26457865, PMID 26906190, PMID 27317442, PMID 27682068, PMID 29954418, PMID 36965196, PMID 41277847
2009 (1), 2017 (1)